人类OAT1的冷EM结构揭示了药物结合和抑制机制
Hyung-Min Jeon1, Jisung Eun1, Kelly H Kim2
1Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.
Structure (London, England : 1993)
|August 22, 2025
概括
对人体有机离子载体1 (hOAT1) 的结构洞察力揭示了像奥尔梅沙坦这样的基质和像普罗贝尼西德这样的抑制剂是如何结合的. 这说明了传输机制和潜在的药物相互作用.
科学领域:
- 生物化学
- 结构生物学
- 药理学
背景情况:
- 有机离子载体1 (OAT1) 对药物代谢和处置至关重要.
- 了解OAT1的结构是预测药物相互作用的关键.
研究的目的:
- 阐明人类OAT1 (hOAT1) 基质和抑制剂运输的结构基础.
- 研究特定残留物和离子在hOAT1功能中的作用.
主要方法:
- 确定了hOAT1的四个低温电子显微镜 (cryo-EM) 结构.
- 分析的apo,基质结合 (olmesartan) 和抑制剂结合 (probenecid) 形式.
主要成果:
- 确定了Ser203在化物协调和Olmesartan运输中的作用.
- 显示的抑制剂阻断基质的进入/退出,增加保留.
- 发现基质与抑制剂结合的结构差异.
结论:
- OAT1结构提供了对基质识别和抑制机制的见解.
- 这些发现有助于开发具有更少相互作用和更好的药物.
- 离子在OAT1中介的传输中起着关键作用.
更多相关视频
09:30Author Spotlight: Exploring Cellular Processes by Modeling Ligands in Cryo-EM Maps
Published on: July 19, 2024
1.5K
18:45Harvesting and Cryo-cooling Crystals of Membrane Proteins Grown in Lipidic Mesophases for Structure Determination by Macromolecular Crystallography
Published on: September 2, 2012
25.2K
相关概念视频
Cryo-electron Microscopy
3.6K
Conventional electron microscopy (EM) involves dehydration, fixation, and staining of biological samples, which distorts the native state of biological molecules and results in several artifacts. Also, the high-energy electron beam damages the sample and makes it difficult to obtain high-resolution images. These issues can be addressed using cryo-EM, which uses frozen samples and gentler electron beams. The technique was developed by Jacques Dubochet, Joachim Frank, and Richard Henderson, for...
3.6K
Protein-Drug Binding: Mechanism and Kinetics
931
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
931
Gene Families
9.1K
Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
9.1K
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Drug Binding to Blood Components
249
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
249
